Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
Kwon, Y.D., Georgiev, I.S., Ofek, G., Zhang, B., Asokan, M., Bailer, R.T., Bao, A., Caruso, W., Chen, X., Choe, M., Druz, A., Ko, S.Y., Louder, M.K., McKee, K., O'Dell, S., Pegu, A., Rudicell, R.S., Shi, W., Wang, K., Yang, Y., Alger, M., Bender, M.F., Carlton, K., Cooper, J.W., Blinn, J., Eudailey, J., Lloyd, K., Parks, R., Alam, S.M., Haynes, B.F., Padte, N.N., Yu, J., Ho, D.D., Huang, J., Connors, M., Schwartz, R.M., Mascola, J.R., Kwong, P.D.
J.Virol.